Holen Sie sich die Stockscreener-App
1.81
0.56%
0.01
Schlusskurs vom Vortag:
$1.80
Offen:
$1.79
24-Stunden-Volumen:
9,693
Relative Volume:
0.02
Marktkapitalisierung:
$4.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.87M
KGV:
-0.0793
EPS:
-22.8335
Netto-Cashflow:
$-15.59M
1W Leistung:
-2.16%
1M Leistung:
+2.84%
6M Leistung:
-29.84%
1J Leistung:
+124.34%
1-Tages-Spanne:
$1.75
$1.84
1-Wochen-Bereich:
$1.6537
$1.96
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
1.84 | 4.04M | 0 | -16.87M | -15.59M | -22.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.80 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.16 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.65 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Why Indaptus Therapeutics Inc. stock remains on buy listsWeekly Stock Report & Safe Entry Momentum Tips - Naître et grandir
Will Indaptus Therapeutics Inc. stock keep outperforming rivalsWeekly Trade Summary & Safe Entry Zone Identification - Naître et grandir
Indaptus Therapeutics Inc expected to post a loss of $4.36 a shareEarnings Preview - TradingView
Does Indaptus Therapeutics Inc. have declining or rising EPSPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
Indaptus Therapeutics (INDP) Expected to Announce Quarterly Earnings on Thursday - Defense World
CapEx per share of Indaptus Therapeutics, Inc. – NASDAQ:INDP - TradingView
Lazar takes 98% control stake in Indaptus Therapeutics (INDP) via $6M deal - Stock Titan
Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement - marketscreener.com
Indaptus Therapeutics shareholders approve preferred stock conversion and company charter amendments - Investing.com
Indaptus (INDP) director Jerome Jabbour awarded options on 25,000 shares - Stock Titan
Indaptus Therapeutics (NASDAQ: INDP) investors back control shift, share boost - Stock Titan
Indaptus Therapeutics (INDP) director Jerome Jabbour files initial Form 3 - Stock Titan
Rate Hike: Why is Indaptus Therapeutics Inc stock going up2025 Trading Recap & Weekly Stock Performance Updates - baoquankhu1.vn
Indaptus Therapeutics (INDP) director discloses holding 25,000 common shares - Stock Titan
INDP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Summary: Can Champion Homes Inc reach resistance levels soonGap Up & Verified Swing Trading Watchlist - baoquankhu1.vn
INDP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does Indaptus Therapeutics Inc. have a sustainable dividend2025 Technical Overview & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Can Indaptus Therapeutics Inc. stock reach $100 price target2025 Support & Resistance & Accurate Buy Signal Notifications - mfd.ru
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support - TipRanks
Indaptus Therapeutics Signs Multiple Material Agreements - TradingView
What’s the analyst consensus on Indaptus Therapeutics Inc.Market Volume Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is Indaptus Therapeutics Inc. stock undervalued right nowJuly 2025 Review & Risk Managed Trade Strategies - mfd.ru
How Indaptus Therapeutics Inc. stock benefits from strong dollarMarket Rally & Real-Time Volume Trigger Notifications - mfd.ru
Published on: 2026-02-04 21:21:37 - baoquankhu1.vn
Is Indaptus Therapeutics Inc.’s ROE strong enough2025 Top Decliners & Target Return Focused Picks - mfd.ru
Retail Trends: Why is Indaptus Therapeutics Inc stock going down2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn
Update Recap: Whats next for Indaptus Therapeutics Inc stock2025 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Insider Trends: Why is Indaptus Therapeutics Inc stock going up2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation - Investing.com India
Indaptus Therapeutics cuts executive pay, director stays on - TipRanks
Indaptus Therapeutics adjusts executive salaries and board member rescinds resignation By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Board Member Decision - TradingView — Track All Markets
Aug Wrap: Is Indaptus Therapeutics Inc stock a buy or sellMarket Risk Summary & AI Driven Price Forecasts - baoquankhu1.vn
MACD Signal: Is Indaptus Therapeutics Inc stock a good pick for beginnersEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Will Indaptus Therapeutics Inc. stock recover faster than marketFit and Size Notes & lightweight options for faster days - ulpravda.ru
Indaptus Therapeutics Appoints David Natan to Board - The Globe and Mail
Indaptus Therapeutics appoints David Natan to board and audit committee By Investing.com - Investing.com Australia
Indaptus Therapeutics appoints David Natan to board and audit committee - Investing.com
Will Indaptus Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Technicals & Entry Point Confirmation Alerts - Улправда
How analysts rate Indaptus Therapeutics Inc. stock todayEarnings Risk Report & Weekly Hot Stock Watchlists - Улправда
Why did INDP stock gain 12% today? - MSN
Indaptus Therapeutics announces upcoming board leadership transition - MSN
Three Indaptus Therapeutics board members signal planned resignations By Investing.com - Investing.com Nigeria
Three Indaptus Therapeutics board members signal planned resignations - Investing.com
Indaptus Therapeutics Announces Board Resignations - TradingView — Track All Markets
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Up 25.9% in December - Defense World
Indaptus Therapeutics looks to raise $2.25M in private placement - MSN
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - marketscreener.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Globe and Mail
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):